Dechra Veterinary Products, manufacturer of the leading feline hyperthyroidism treatment Felimazole®, has launched a new website for cat owners about the disorder: www.hyperthyroidcat.co.uk
The website is an online version of Dechra's popular client booklets on feline hyperthyroidism and, since its launch, has averaged 500 unique visitors a month. With pages on diagnosis, treatment and even tips on how to give a pill to a cat, owners now have a place to go for more information and advice on the disease.
Matthew Olsen, product manager at Dechra Veterinary Products says: "This website is perfect for helping owners better understand and manage hyperthyroidism in their cat. It's also useful for practices as they now have somewhere to refer owners to for more information about the diagnosis and management of this complex hormonal disease."
Cards with the new website address are available for practices to hand to clients, along with waiting room posters that will serve as a further reminder of the new site. "The website allows clients to browse the site in the comfort of their own home and is also ideal for practices with limited storage space for client information materials," Dr Olsen continues. "The posters, cards and website enhance Dechra Veterinary Products' existing range of marketing materials available to vets and owners on the subject of feline hyperthyroidism."
Dechra also encourages practices that have their own websites to link directly to http://www.hyperthyroidcat.co.uk/. Practices can order posters and hand-out cards by contacting Dechra on 01743 441632 or email: info@dechra-uk.com
kcs-intervet.swfIntervet / Schering-Plough Animal Health is running a challenge over the next few months to encourage the early diagnosis of Keratoconjunctivitis sicca (KCS), a painful disease which leads to permanent blindness (see right).
Practices are being asked to perform a Schirmer Tear Test (STT) on 50 dogs not previously diagnosed with KCS for the chance to win one of 70 Samsung digital cameras.
Recent studies¹ have shown the incidence of KCS to be 4.6% of the UK dog population, rising to 8.3% in predisposed breeds. However, 20 veterinary practices have recently participated in an Early Diagnosis Programme and the number confirmed with KCS was 9.7%². 17 of the cases diagnosed had Schirmer Tear Test readings of zero.
KCS is thought to be under-diagnosed because not all cases have the classic 'textbook' appearance but look surprisingly normal despite severely reduced tear production. In addition, diagnosis usually requires clinical suspicion and a Schirmer Tear Test.
Claudia Hartley, BVSc CertVOphthal DipECVO MRCVS, European Specialist in Veterinary Ophthalmology believes that: "All sore eyes (except where a descemetocoele is present) should have a Schirmer Tear Test, whether or not there is corneal change."
Melanie Dass MA VetMB CertSAM MRCVS ACIM, Product Manager for Optimmune said: "The results of our Early Diagnosis Programme made interesting reading and supported what we have always suspected - that KCS is under-diagnosed. It's really important that dogs suffering from this disease are detected promptly as early diagnosis and treatment with Optimmune gives the best prognosis.
"As part of the Early Diagnosis Programme owners of predisposed breeds received a personalised mailing offering them a free Schirmer Tear Test and some practices also elected to test all breeds at routine consultations such as vaccination. The tests were generally performed by veterinary nurses after they had received training, with the diagnosis made by a veterinary surgeon."
For more information about KCS, Optimmune and support in implementing an Early Diagnosis Programme, please contact your local Intervet / Schering-Plough Animal Health Territory Manager or call 01908 685685.
References¹ Pierce V & Williams D, 2006. Determination of Schirmer Tear Tests values in 1000 dogs. BSAVA Abstract 2006.² Intervet / Schering-Plough Animal Health Practices Study 2009
Researchers at the Royal Veterinary College (RVC) have developed a system that eliminates the need for antibiotics and resistance genes in the engineering of industrial and medical products.
The method involves safer, less costly alternatives and is well suited for industrial production of many biofuels and biopharmaceuticals. This research has been published in the online access journal BMC Biotechnology.
Genetic engineering underpins much of biotechnology, and antibiotic selection of engineered strains is a key tool. Unfortunately, antibiotic selection methods risk spreading resistance traits, particularly as biotechnology products move into the environment and clinic. There have been alternatives, but none are satisfactory for wide application.
Gene targeting is the insertion of DNA into specific sites or genes within the genome of selected cells in order to alter gene expression for a particular purpose.
While working on gene targeting in bacteria, RVC researchers discovered that a well-known interaction between a cell membrane synthesis gene and the biocide triclosan could be exploited for strain selection. Surprisingly, triclosan selection performs better than conventional antibiotic selection.
"We think this simple technology is well suited for industrial scale fermentations that produce a range of valuable products, including bio-fuels and bio-pharmaceuticals," said Dr Liam Good, at the Royal Veterinary College and lead researcher on the project. "More importantly, the new system is relatively safe and inexpensive, because the gene is native in all bacteria and triclosan is approved for use in many household applications."
The research was carried out with Dr Shan Goh of the Department of Cell and Molecular Biology, Karolinska Institute, Stockholm.
Protexin Veterinary has launched CystoPro, a new product to aid in the management of urinary tract infections in dogs.
According to the company, the key active ingredients in the new product are proanthocyanidins (Type A PACs), derived from cranberries, which work by reducing the ability of E.coli bacteria to infect a dog's urinary tract.
In addition, CystoPro contains the probiotic Enterococcus faecium (NCIMB 10415) E1707 which Protexin says reduces pathogenic bacteria within the gastrointestinal tract thereby lessening the risk of ascending UTIs of faecal origin.
The product also contains Mannan-oligosaccharide (MOS), which Protexin claims binds E.coli and upregulates the innate immune system by attracting phagocytes to opsonise the bacteria.
Lastly CystoPro contains N-acetyl D-glucosamine which is said to reinforce the structure of the Glycosaminoglycan (GAG) layer that lines and protects the bladder urothelium.
CystoPro is available in boxes of 30 and 120 capsules.
VetSurgeon.org has today launched 'Claim CPD', a new feature which allows members to claim time spent on the site towards the annual requirement for 35 hours documented Continuing Professional Development.
The system has been designed to make recording CPD-qualifying activity, both reading or viewing content and participating in forum discussions, as quick and easy as possible.
Clicking the 'Claim CPD' button towards the top right of a content page on VetSurgeon.org reveals a drop down box into which you tap in the time you've spent on the subject, together with optional notes to remind you what you learned and how you plan to put it into practice.
In your VetSurgeon.org profile, there's a new tab marked 'CPD', visible only to you. Click that to reveal a list of all the time you've accrued, with links back to the content you've recorded towards your CPD. You can also produce a certificate covering the time you've logged in a given period, and upload it to your RCVS PDR.
Claim CPD can be used in various sections of VetSurgeon.org:
FORUMS Now there's more reason than ever before to join forum discussions, ask questions and help each other, because when you learn something in the process, you can record it towards your CPD allowance.
NEWS You may not think it's worth recording the short period of time you spent reading a news story on VetSurgeon.org as CPD. But if the story prompted you to spend time finding out more information, it probably is. For example, say you read about a new POM. You spend a couple of minutes reading about it on VetSurgeon.org. But then you visit the manufacturer's website to learn more about it and discuss it with the Territory Manager. Now it has become a worthwhile amount of time to record.
CPD Claim CPD can also be used to record and claim time spent at any event listed in our CPD and Events Diary. So now you can RSVP to the event AND claim a certificate afterwards. Of course, most of the providers supply their own certificates, but useful for when they don't and if you should misplace your certificate.
GALLERIES Now you can claim any time spent watching videos in the VetSurgeon Galleries towards your CPD requirement (indeed, this new feature was inspired by a veterinary surgeon who contacted us to ask for a certificate for precisely that). In addition, if you contribute a clinical image to our curated galleries, and learn something from the curator's comment, you can claim that too.
Arlo Guthrie, VetSurgeon.org Editor said: “I often hear members remark almost guiltily about how much time they spend on VetSurgeon.org. Now there's no need to feel guilty! Sharing knowledge amongst yourselves in forums has always been a great way to learn, recognised by the RCVS. But now, we've made it really easy to document what you've learned, in good time for the requirement to document all CPD from the start of next year."
VRCC veterinary referral centre, the leading European veterinary cancer treatment centre, has announced that it has installed what is believed to be the first and only new 'Human' CT scanner in a UK private small animal veterinary centre, at a cost of nearly £500,000. The announcement came less than a year after the centre's 6 million volt linear accelerator went online - currently the only veterinary radiotherapy facility in the UK. Apart from routine scans required by all the clinicians at the centre, VRCC also takes referrals in medicine, surgery and oncology. Its CT will also be used in conjunction with the linear accelerator, offering sophisticated cancer treatments previously not available in the UK. In another first for VRCC, the centre has appointed Tom Jackson BSc Radiography (T), a therapeutic radiographer from Guys & St Thomas Westminster, a centre of excellence in oncology. Tom will be working under the direction of the centre's clinical director, Dr Susan North, the most highly qualified and experienced veterinary oncologist in the UK and the only qualified radiation veterinary oncologist in the UK.
For more information about the referral services available from VRCC, visit http://www.vrcc.co.uk/, or ring 01268 564664.
Following ongoing lobbying by the British Veterinary Association and others, the Veterinary Medicines Directorate has dropped controversial plans for a new veterinary medicines category - POM EA (prescription-only medicine extended administration).
The proposed category has been discussed at the Veterinary Products Committee (VPC) since 2009. The original purpose was to provide a new category under which a veterinary surgeon would make a clinical assessment and, if appropriate, issue a Veterinary Permission of Extended Administration (VPEA) allowing the animal holder to obtain the prescribed POM EA medicine (from a veterinarian, pharmacist or SQP) for up to 36 months from the date of authorisation.
The BVA, along with its specialist divisions, says it opposed POM EA from the outset and failed to see that there was any justification for a new category. Veterinary surgeons are already able to write prescriptions for extended use and, as most health plans are reviewed annually, anything beyond a yearly assessment would be unacceptable on health and welfare grounds. An additional category would have also taken the UK even further out of step with the rest of the EU.
The BVA submitted written comments and attended a stakeholder meeting with the VMD to discuss concerns. Despite the VMD suggesting revisions to the original proposal the BVA and other stakeholders maintained that the new category was unnecessary.
Following these consultations, the VPC decided, at a meeting in March, not to progress the proposal any further.
Harvey Locke, President of the BVA, said: "We are extremely pleased that the Veterinary Products Committee has listened to our concerns and decided to drop its plans for POM EA.
"The BVA felt strongly that the proposed new category was unnecessary at best and potentially harmful to animal health and welfare at worst.
"In all fields of practice veterinary surgeons would not feel comfortable prescribing for such long periods without regular contact with the animals they care for."
ProteqFlu, the live attenuated canarypox equine influenza (EI) vaccine, has had its shelf life extended from 27 to 36 months.
Merial says the increased shelf life is the result of ongoing investment in vaccine research & development, and that the new data underpins the stability of modified live vaccine technology.
Merial highlights that ProteqFlu is the only equine flu vaccine in Europe to include the updated American clade 1 Ohio/03 strain in accordance with the OIE recommendations (2004).
Vets, consultants and other advisors should encourage dairy farmers to make use of available information to help improve their herd's performance and profitability through breeding. This is the message from DairyCo breeding+ director, Marco Winters, who says farmers should use genetics to improve not only milk production, but also health, welfare, management and type traits.
Breeding briefs, a new booklet from DairyCo, identifies some genetic improvement tools that allow farmers to make better breeding decisions and concentrates on how to use them in practice. And for those who feel confronted by an overload of information, the booklet helps identify the figures to seek out and prioritise.
Breeding decisions are cumulative: their effects build up over the generations so a problem can be introduced or cured over just a few years. A series of poor breeding decisions can mean the difference between profit and loss; even between a business's survival and failure. Yet the time, cost and effort needed for a good breeding decision to be made is much the same as those needed for a bad one.
Mr Winters says: "High quality cattle are at the heart of profitable dairy farming and this requires good quality genetics. Without these, however good farmers' management, there is a ceiling to their herd's performance and profitability. Vets, consultants and other dairy advisers have an important role to play in helping farmers access the information they need to make informed decisions."
DairyCo Breeding briefs is available to download from http://www.dairyco.org.uk/. To request a pdf version by email call 01285 646510 or email: publications@dairyco.org.uk.
VRCC the Essex-based veterinary referral specialists and centre for the treatment of cancer in dogs and cats has become the first in the UK to offer a canine melanoma vaccine.
The vaccine, previously only available in the U.S. where it has been granted a conditional license by the USDA, has been made available to VRCC's Head of Oncology Dr Susan North who fulfils the US Academic Credentials required.
According to VRCC, most oral tumours are not noticed early by owners, so many go undiagnosed and untreated until they are advanced and the dog has a poor chance of recovery.
Canine melanoma is an aggressive neoplasm treated with surgery and/or radiation therapy, which readily metastasises to the lymph nodes, liver, lungs and kidneys but is chemo-resistant. There is little evidence that chemotherapy improves survival time.
The canine melanoma vaccine develops effective immunotherapy in dogs that recognises and targets specific antigens on melanoma cells and may account for long-term tumour control and survival.
The vaccine is indicated for dogs with stage II or stage III oral melanoma for which local disease control has been achieved: negative local lymph nodes or positive lymph nodes that were surgically removed or irradiated.
The conditional license was granted based on the reasonable expectation that when used along with surgery and/or radiation therapy to treat the initial tumour the vaccine may help extend survival time and improve quality of life in dogs with canine oral melanoma.
US research concluded that canine patients with advanced disease have a median survival time of less than 5 months with standard therapies. In initial trials, dogs receiving the vaccination sequence had a median survival time of 389 days.
A canine transdermal device is especially matched to the vaccine for needle-free delivery and optimal distribution. Veterinary surgeons with a patient with oral melanoma should contact Dr Susan North at VRCC, www.vrcc.co.uk to discuss the case at an early stage, as initial treatment is important to ensure suitability for the vaccine.
CEVA Animal Health is launching a new TV advertising and marketing campaign to promote its veterinary behaviour products, DAP and Feliway, in the run up to this year's firework season.
The campaign will feature a new animated character 'Dap the Dog', who will join 'That Purple Cat' in educating pet owners on the behaviours expressed by pets that are fearful of loud noises during fireworks, and the benefits of using DAP and Feliway. The adverts will be aired throughout October on ITV2, E4, More4 and Channel 4 (London only) starting on Monday 4th October and will be seen by 11.5 million ABC1 women.
A range of firework marketing materials have been produced to support veterinary practices and help educate owners who have noise phobic pets. These include client leaflets, an A4 leaflet holder, waiting room display materials and a firework poster all featuring the characters from the advert. CEVA's petfireworkfear website - www.petfireworkfear.co.uk/ - has also been updated to include the new TV advert, downloadable versions of all materials and tips on how to prepare pets for fireworks. In addition, www.dapfordogs.com/ and www.feliway.com/ will feature a voucher offering pet owners a free 60ml spray when they purchase a DAP or Feliway diffuser from their local veterinary practice.
The support comes in light of recent research1, carried out by CEVA, that revealed 80% of pet owners have had a pet that has been afraid of fireworks, with more than half of dog owners wanting to ban them altogether because they are too upsetting for their animals.
Julia Wood, product manager at CEVA Animal Health, said: "Fireworks are the most stressful event that a pet can experience and, in most cases, owners have noticed their animals becoming visibly unsettled with 49% of dogs shaking1 and 65% of cats hiding1. The new TV advertising campaign and marketing support will educate pet owners on behaviours expressed by pets with a fear of loud noises and the importance of taking proactive action by using DAP and Feliway."
CEVA will be running its annual firework display competition amongst veterinary practices throughout October for the best decorated waiting room.
For further information on CEVA's firework campaign or its marketing support, please contact your local CEVA territory manager or call CEVA Animal Health on 01494 781510.
The Feline Advisory Bureau (FAB) has teamed up with Agria Pet Insurance to provide insurance cover for cats in the UK, with each policy generating a donation to the work of FAB and its International Fund for Cat Welfare.
Ross Tiffin, FAB's Strategy and Business Adviser said: 'In Agria, we have found a respected company that shares our ethos - it believes in sharing information to makes cats' lives better. One of the leading pet insurers in the world, Agria has been insuring pets since 1890 and has shared information on longevity and disease patterns with university researchers for many years.'
Claire Bessant, Chief Executive of FAB said: 'FAB has always been an enthusiastic supporter of health insurance for cats - we want cats to receive the best treatment without owners having to worry about the cost. Our support has now taken on a practical form in the shape of a general pet insurance guide and, through working closely with Agria, by providing cat owners with an excellent insurance option.'
To view A fabcats guide to cat insurance go to www.fabcats.org/catinsurance. The guide gives generic advice on choosing insurance.
For more information on Fabcats Cat Insurance from Agria go to www.fabcats.org/catinsurance or call Agria on 0800 369 9441.
The London Vet Show, which takes place on Thursday 19th November and Friday 20th November at the Olympia Grand, has announced the business programme for 2015.
The programme will include:
Rob Chapman, group event director of the London Vet Show and France Vet said: "The business programme at the London Vet Show has gone from strength to strength with a plethora of informative lectures from top class industry leaders. The informative content includes hints and tips that veterinary professionals can utilise in practice to help enhance their veterinary teams, increase profits and develop their business.”
For further information on the business programme at the London Vet Show or to register for the show visit londonvetshow.co.uk/business.
Ceva Animal Health has launched a National Pet Census to collect information about the UK's domestic dog and cat population.
The Pet Census includes a range of questions on pet ownership including: the number of dogs and cats in a household, where the animals came from and their names, colour and whether they have a passport. Pet owners will also have the opportunity to complete an online 'pet-ition' to campaign for pets to be included in the next Census, earmarked for 2021.
Rachel Levy, communications manager at Ceva Animal Health, said: "The current Household Census states that everyone should be included - but it appears that they have forgotten to include pets, which are valued members of the family! While our National Pet Census is a bit of fun, there is a serious point to it as we will be able to gauge valuable information about pet ownership including where people get their pets from, popularity of breeds and how often a pet goes to the vet."
To fill out Ceva's National Pet Census, visit secrettohappypets.com or the 'That Purple Cat' page on Facebook by 30 April.
Vetoquinol has announced that the 50g pack size of Ipakitine will shortly be replaced by a 60g pot.
The company says this will provide the convenience of a 30 day supply for a 5kg cat or dog who is on 1g/5kg bodyweight twice a day (one level scoop twice a day).
The 60g pot will be available from the end of December. Also at this time, the existing 150g size pot will be replaced by a 180g pot.
The new packaging is more eye-catching, easier to read and gives more description. A 300g pot will also be available in February 2012. Pricing will be in-line with increase in pack size, so proportionally a 20% increase for 20% more product.
Ipakitine is a phosphate binder formulated specifically for veterinary use. It is designed for both cats and dogs and is available as a tasteless powder formulation for easy administration with food.
The BSAVA has announced Richard Dawkins as its headline speaker at BSAVA Congress 2013 next April.
Richard follows in the footsteps of Lord Robert Winston and Susan Greenfield as the special speaker for the BSAVA lecture.
The talk, sponsored by Anistel, takes place on the Thursday afternoon of in Hall 1 and is open to all Congress delegates.
Dawkins is a prolific writer who first came to prominence with his 1976 book The Selfish Gene, his strident manifesto for secularism. However it is The God Delusion that now finds him so frequently called upon for comment. Along with Stephen Hawkins, he is one of the few scientists that members of the public can easily identify, in part due to his willingness to engage in academic and media debates.
Dawkins was born in Nairobi in 1941 where his father worked for British colonial service. He returned to Britain after the war to grow up on the family's estate farm. He studied zoology at Balliol College, Oxford, where he was tutored by Nobel Prize-winning ethologist Nikolaas Tinbergen, graduating in 1962. He received his M.A. and D.Phil. degrees by 1966, and remained a research assistant for another year, when his research concerned models of animal decision-making.
He has since been an assistant professor of zoology at the University of California, Berkeley, and a lecturer and reader in zoology at University of Oxford. In 1995 he was appointed Simonyi Professor for the Public Understanding of Science, a position that had been endowed by Charles Simonyi with the express intention that the holder "be expected to make important contributions to the public understanding of some scientific field", and that its first holder should be Richard Dawkins.
Image courtesy Zoe Margolis
The RCVS Council has approved the new Strategic Plan designed to bring the College closer to its vision of enhancing society through improved animal health and welfare, over the next three years.
The Strategic Plan is founded on feedback from the profession and the public about what the College does well and where it could do better, and an analysis of how other leading regulators operate. It includes 35 actions, clustered under five themes, all centred on the purpose of setting, upholding and advancing veterinary standards.
For example, the College aims to introduce a service charter - for the public and the profession - of rights, expectations and responsibilities for each of its functions.
Nick Stace, RCVS CEO said: "This drive for excellent service lies at the heart of our focus on improvement.
"The concept of veterinary surgeons and veterinary nurses, as well as the public, being our 'customers', was one that unsettled the profession when it was first mooted. But I believe that only by ensuring that we focus relentlessly on improving how we interact with our customers will we deliver a service for the profession, the public, and, ultimately, the UK's animals, which is worthy of the name first-rate regulator."
Amongst other things, the Plan also commits to:
The Strategic Plan can be downloaded from www.rcvs.org.uk/strategy.
Also at its November meeting, Council approved:
More information on all of these topics will be available in the November issue of RCVS News, online shortly at www.rcvs.org.uk/publications.
You can also hear direct from the CEO via his post-Council video update: www.youtube.com/rcvsvideos.
Forum Animal Health is launching a new programme designed for transition cows to help avoid milk fever relapses: the Milk Fever Pack.
According to the company, the new Milk Fever Pack provides a continuous and complete supply of readily available oral calcium to avoid relapses which also gives the cow extra support until her system is back in control. Unlike intravenous calcium, oral calcium will not suppress parathyroid hormone (PTH) release and therefore will not turn off the cow's natural mechanism to regulate blood calcium levels.
Each pack contains one sachet of Agger's® Fresh Cow which supplies essential calcium, energy and rehydrates the cow; and two tubes of Botonic® Calcium which create a mild metabolic acidosis to enable the cow to mobilise calcium efficiently.
Forum Animal Health says the new Milk Fever Pack has been developed in close collaboration with a leading veterinary nutritionist to allow veterinary surgeons to be involved at an earlier stage. The veterinary surgeon can then leave a follow-up protocol for the client to use, helping to avoid milk fever relapses. It gives veterinary surgeons a chance to introduce standard operating procedures into herd health plans bringing better control of milk fever on farms.
For more information, please contact Forum Animal Health on 01737 781416 or animal.health@forumgroup.co.uk.
Changes to the registration procedure for veterinary surgeons, which are being put forward for approval by the Privy Council, have caused some concern in the profession.
Most contentious is the new requirement for veterinary surgeons to confirm their contact details annually, or face removal from the register.
Judging from the remarks in the VetSurgeon forums, many in the profession see this as just another example of bureaucratic-big-brother-pen-pushing-time-wasting (a perception that probably hasn't been helped by the RCVS stating that the change is driven by the need to meet EU Directive 2006/123/EC). Nor would Lynne Hill's remarks have done anything to calm the situation. She said: "If that [the requirement for vets to confirm their address once a year] is beyond the wit and the capability of supposed professional people that we expect to follow a guide to professional conduct, to act as professionals in everything that they do, then I really despair of this profession.
"I do not see anything wrong with the College asking people to confirm their address year in, year out when they make a payment. And if those people cannot be responsible for doing that then they deserve to go forward to be taken off the Register because, if they can't do that, God only knows what else they may well be doing in their professional lives!"
At face value, it's completely understandable why the new regulation was bound to get members' backs up. I mean, the threat of losing your license to practise because you didn't confirm something which hasn't changed anyway. It's a bit extreme isn't it?
The truth of the matter is probably a little more prosaic:
At present, many members pay registration fees by standing order, and may never have updated their contact details. You could argue that it is only right that the authority changed with regulating veterinary surgeons knows how to get hold of them. If a consequence of this is also that the RCVS is able to work more efficiently and cost-effectively (apart from anything else, it shouldn't have to spend so much time tracking down and chasing non-payers), then so much the better.
Alternative remedies which could be dangerous to pets are being targeted by the Government in a major drive to improve animal health and welfare. Some herbal and homeopathic products are claiming medicinal benefits without scientific proof, meaning they may not properly treat or prevent serious diseases, leaving pets at risk.
The Veterinary Medicines Directorate’s (VMD) Director of Operations, John FitzGerald, said: "Some of these products are claiming to be effective and safe when no scientific evidence has been presented to us to show they are.
"Animal owners have a right to know if a product does what it claims. The products claim to treat diseases which can cause serious welfare problems and in some circumstances kill animals if not properly treated. So in some cases owners are giving remedies to their pets which don’t treat the problem."
A number of unauthorised products are being targeted, including:
From now on, the VMD will be contacting manufacturers to ensure that they demonstrate the products are safe and provide the benefits which they claim to. If this is not the case the manufacturers will be required to re-brand the products to make it clear they are not medicinal.
Supporting the action, British Veterinary Association President Harvey Locke said: "As veterinary surgeons we rely on the use of safe, effective and quality medicines for the health and welfare of animals under our care – and there must always be sound scientific evidence to back up medicinal claims made by the manufacturer of any product.
"Some of these unauthorised products may at the least be ineffective and at worst could cause harm because serious life-threatening diseases may go undiagnosed. We would urge animal owners always to check with their veterinary surgeon before giving any remedy or supplement to their pet."
The World Small Animal Veterinary Association has established a new Foundation with a remit to improve global companion animal care through science and education.
The WSAVA Foundation, a not-for-profit body, is now identifying a range of potential projects, which it says are likely to include:
It is also identifying sources of funding, grants and partnerships with the veterinary pharmaceutical and pet nutrition sectors and other potential donors.
Dr Larry Dee, WSAVA Foundation President, former WSAVA President and co-owner of a large companion animal practice in Florida, said: "The creation of this new Foundation is one of the WSAVA's most exciting initiatives to date. We have an ambitious vision to improve global companion animal care through science and education.
With its establishment, global veterinary medicine now has a wonderful opportunity to utilize the networking resources and global 'connectivity' of WSAVA to deliver on its goal of improving companion care everywhere. We will be announcing details of our first initiatives shortly."
For further information on the WSAVA Foundation, please contact the WSAVA Secretariat at wsavasecretariat@gmail.com.
Veterinary surgeons and veterinary nurses will be able to try their hands at the Royal College of Veterinary Surgeons code-cracking competition at the London Vet Show at Olympia on 24-25 November.
At the RCVS breakfast session on the Friday morning (8.30, part of the Business Stream), President Dr Jerry Davies will unlock the secrets of the proposed new Codes of Professional Conduct for vets and VNs.
To promote this breakfast session, the RCVS is inviting visitors to come to its stand (J90) to solve photo enigmas, using clues provided to decipher a series of words that appear in the proposed new Codes. The winner will be in line to receive a pair of super sleuthing video glasses.
VNs who missed BVNA Congress can also get their hands on a 50th anniversary commemorative chocolate medallion by visiting the RCVS stand.
Coffee and pastries will be served at the morning session on Friday - there's no need to book, just turn up.
A new company supplying pet chews to the veterinary profession has launched this month.
The Soft Chew Company has been set up by Kevin Ingram, owner of the veterinary supplier J.A.K Marketing and Niall McFerran, who has in the past worked for a number of veterinary healthcare companies including Animalcare, Ceva and Alstoe.
Kevin said: "The healthcare supplement market in the UK is worth over £20 million and rising but most customers are asked to use products which were designed for use on humans. The aim of The Soft Chew Company is to provide those health benefits in the form of treats that the dogs and cats will readily accept."
The new company's product range will be branded: "Chewz" and marketed as palatable healthcare supplements in order that they will not be confused with pharmaceutical products.
The range will initially consist of:
The Chewz range can be obtained from all wholesalers or directly from J.A.K Marketing.
For further information contact; info@thesoftchewcompany.co.uk or 01347 293150
The review coincided with a move last month from RUMA, the agricultural and food industry alliance which promotes responsible use of medicines in farm animals, to align with the EMA position.
The announcement means that under PVS guidelines, fluoroquinolones, 3rd and 4th generation cephalosporins and colistin will retain Class 3 status. This means they are only used when no other options are available and when supported by laboratory sensitivity testing – or exceptionally when all other options have failed.
Class 1 antibiotics form the standard prescribing list within responsible use guidelines and Class 2 are used only when sensitivity tests or clinical experience proves standard antibiotics are not effective. In all treatment decisions the health and welfare of the pigs must always take priority.
Betalactams with betalactamase inhibitors (clavulanic acid) were previously in the highest priority Class 3 but in light of the list defined by the EMA, which has been adopted by the Veterinary Medicines Directorate as well as RUMA, the PVS has reassessed the risk and moved them to Class 2 to align them with plain betalactams. This means they are still subject to voluntary restrictions, but their use would not necessarily be only as a last resort.
PVS president Mark White said that despite the ongoing review process and the potential to reclassify certain products, the Society’s underlying principles remain unchanged: "The total amount of all antibiotics used on pig farms to treat and prevent disease should be minimised, and the types of antibiotics used in pigs should be considered in light of the implications for antibiotic resistance challenges in both pigs and man.
"This policy is proving successful with AHDB Pork’s electronic pig medicine book (e-MB) recently showing that use of colistin appears to have fallen by over 70% in 2016 following its move to a Class 3 antibiotic in late 2015.
"We must also continue to be alert to the possibility of cross resistance, even in older antibiotics that have little or no use in humans. Risk must be acknowledged where it exists and overall reductions are still imperative."
RUMA has welcomed the review and alignment from the PVS. Secretary General John FitzGerald said: "Farmers and vets need boundaries within which to operate and clear objectives to meet, and we would urge all supply chains, from farmer to retailer, to align with the sector position on best practice use of antibiotics, as defined by each sector’s professional veterinary organisation."